Bahram Alamdary Badlou
Biography
Dr. Bahram A. Badlou is a distinguished Hemato-Cardiologist and biomedical researcher with a strong focus on nanomedicine, drug delivery systems, immunology, and platelet function. With a PhD in Clinical Biochemistry and a background in both pharmaceutical sciences and clinical diagnostics, Dr. Badlou has held multiple academic and research positions across the Netherlands and the Middle East.
He has authored numerous peer-reviewed publications and serves as a reviewer and editor for several international journals. His work bridges the gap between clinical practice and translational biomedical innovation, particularly in cardiovascular and hematological disorders.
Research Interest
Abstract
Post COVID-19 War Era, (Un)Known Carcinogenic Angels of Death Triangle, Increasing Accelerated Excessive Mortality Rates, however: Recent increasing evidence-based studies, and clinical reports are showing that the Accelerated Excessive Mortality rate (AEMR) among cancer patients, become a very concerning issue, indicating significant missing know-how, in the last decade. Moreover, AEMRs (defined as a shortening of the 5-year survival chances) between both Chronic
Cardiovascular patients (CCVPs) and Chronic Cancer patients (CCPs) make almost all TOP-100 University Medical Centers (UMCs) worldwide useless, on the one hand. On the other hand, increased AEMRs indicate that all the TOP-100 UMCs have still not succeeded to updated/upgraded, appropriately/ accordingly. What is known? Previously I introduced death triangle machinery mutual collaborations that was based on the first Prognosis- Diagnosis expanded even into a rectangle/pentagonal, in postcovid-19 pandemic attacks (ref Badlou BA. death triangle different publications). In the last decades, different study groups showed that thrombosis is still one of the main causes of affecting mortality and morbidity rates, either in- hospital or out of hospitals cancer patients. Based on the last Century?s different global research data could be claimed that the main cause (s) of high mortality and morbidity rate is ?death triangle? machineries consisting of Cancer Microorganisms- Platelets (CMP). How these abovementioned (un)known pathologic and Hematologic factors and processes correlated with each other is the main goals of our Research team.
